Opportunity
DIBBS #SPE2DP-27-T-0094
DLA request for Baxter dextrose in lactated Ringer’s injection
Posted
October 14, 2026
Respond By
October 19, 2026
Identifier
SPE2DP-27-T-0094
NAICS
325412, 424210
DLA Troop Support is seeking packaged dextrose in lactated Ringer’s injection for medical supply use. - Government buyer: Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain Pharm FSA. - Requested product: 5 packages of dextrose in lactated Ringer’s injection, identified by NSN 6505-00-116-1064. Each package contains 14 single-dose, 1,000 mL containers (70 containers total). - OEM: Baxter Healthcare Corporation is the approved source. Listed manufacturer part numbers are 2B2074X and NDC00338-0125-04; CAGE 04687 is also associated with the latter part number. - Product requirements: Sterile, nonpyrogenic, latex-free, prescription-only solution for intravenous administration. Each 100 mL contains dextrose, sodium chloride, sodium lactate, potassium chloride, and calcium chloride. - Shelf life and handling: Type I shelf-life requirement of 24 months, non-extendable. Store at room temperature; protect from excessive heat and freezing. - Delivery: FOB destination, required within 5 days after award, to the specified Fort Bragg medical logistics destination.
Description
DEXTROSE IN LACTATED R (QTY: 5, NSN: 6505-00-116-1064, Purchase Request: 7018691099) Approved Sources: - CAGE: 04687, Part No: NDC00338-0125-04 - CAGE: 1G026, Part No: 2B2074X, Company: BAXTER HEALTHCARE CORPORATION - CAGE: 1G026, Part No: NDC00338-0125-04, Company: BAXTER HEALTHCARE CORPORATION